Related Experiment Video
Updated: Jun 10, 2026

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells
Published on: March 28, 2013
Maternal and infant immunity against Bordetella pertussis, Norway, 2020 to 2023
Margrethe Greve-Isdahl1,2, Thea Kristine Rogne Møller2, Terese Bekkevold2
1University of Oslo, Oslo, Norway.
Insights
A high number of pregnant women and infants under three months have low pertussis (whooping cough) antibody levels, indicating significant susceptibility. These findings support maternal pertussis vaccination during pregnancy in Norway.
Area of Science:
- Immunology
- Public Health
- Vaccinology
Background:
- Pertussis (whooping cough) poses a significant health risk to young infants.
- Norway's current infant vaccination schedule uses an acellular pertussis vaccine (aP) in a hexavalent formulation at 3, 5, and 12 months.
Purpose of the Study:
- To assess pertussis susceptibility in mothers and infants to inform vaccination strategies.
- To evaluate the impact of maternal antibodies on infant response to pertussis vaccination.
Main Methods:
- Prospective observational study of 366 mother/infant pairs (2020-2023).
- Blood samples collected from mothers (late pregnancy), cord blood, and infants (pre-vaccination and post-vaccination).
- Multiplex immunoassay used to measure IgG antibody levels against pertussis antigens, diphtheria, and tetanus.
Main Results:
- 48% of pregnant women had low anti-pertussis toxin (PT) IgG levels (<5 IU/mL).
- 72% of infants under 3 months had low anti-PT IgG levels before their first vaccine dose.
- Infants responded well to vaccination; no blunting effect observed from high maternal antibodies.
- Infants born to mothers boosted within 2 years pre-pregnancy showed low anti-PT IgG levels (58% <5 IU/mL).
Conclusions:
- A substantial proportion of pregnant women and young infants exhibit low pertussis immunity, suggesting high susceptibility.
- Findings support the implementation of pertussis vaccination during pregnancy in Norway to protect infants.
- Maternal vaccination may be crucial for maintaining adequate infant antibody levels against pertussis.
Abstract:
BACKGROUNDPertussis remains a serious threat to young infants. In Norway, infants receive an acellular pertussis vaccine (aP) according to a 2 + 1 schedule at 3, 5 and 12 months of age, delivered as a hexavalent vaccine.AIMWe aimed to study susceptibility to pertussis in mothers and infants to guide decisions regarding vaccination in pregnancy.METHODSIn this prospective observational study, we included 366 mother/infant pairs during 2020-2023, collecting blood samples from mothers in late pregnancy, cord blood at delivery and from infants before their first and after their third vaccine dose. We retrieved health registry data on vaccination and pregnancy-related information. IgG antibody levels against pertussis-antigens, diphtheria and tetanus were measured using a multiplex immunoassay.RESULTSOf the pregnant women, 48% (174/366) had low levels of antibodies against pertussis toxin (PT) defined as below 5 IU/mL. Maternal antibodies declined in infants from birth until first vaccination, leaving 72% (154/215) of infants with anti-PT IgG levels below 5 IU/mL. All infants responded well to vaccination and we found no evidence of blunting from high levels (> 40 IU/mL) of maternal antibodies against PT. Infants of mothers who received an aP-containing booster vaccine within 2 years before pregnancy displayed low anti-PT IgG levels, with 58% (15/26) having levels below 5 IU/mL.CONCLUSIONA high proportion of pregnant women and their infants under 3 months of age had low anti-PT antibody levels, indicating high susceptibility to pertussis. The results support the introduction of vaccination against pertussis during pregnancy in Norway.
More Related Videos
14:09High-Throughput Total Internal Reflection Fluorescence and Direct Stochastic Optical Reconstruction Microscopy Using a Photonic Chip
Published on: November 16, 2019
08:04Measuring Mitochondrial Electron Transfer Complexes in Previously Frozen Cardiac Tissue from the Offspring of Sow: A Model to Assess Exercise-Induced Mitochondrial Bioenergetics Changes
Published on: August 16, 2021
Related Concept Videos
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Development of Human Microbiota
Development of the Oral Microbiota
Microbiota of the Respiratory Tract
Respiratory Syncytial Virus Disease